Matt Westoby is an accomplished biopharmaceutical leader with extensive experience in the technical development of protein, cell, and gene-based therapies. They previously held significant roles at Biogen, where they managed process development and technology transfer across clinical programs, and contributed to the successful regulatory filings of over 20 protein therapeutics. Matt currently serves as the Executive Director of Pivotal & Commercial Biologics Development at Gilead Sciences, where they lead the development and characterization of purification processes for the biologic and ADC portfolio. Their innovative approach and leadership have been instrumental in enhancing manufacturing productivity and advancing novel technologies in the biotechnology industry.
This person is not in any teams
This person is not in any offices